✦ LIBER ✦

MAXIMUM LIPID-LOWERING THERAPY FOR FAMILIAL HYPERCHOLESTEROLEMIA: EFFICACY AND SAFETY WITH HIGH-DOSE STATIN, RESIN AND EZETIMIBE

✍ Scribed by Nohara, A.; Noguchi, T.; Tada, H.; Mori, M.; Tsuchida, M.; Takata, M.; Kawashiri, M.; Inazu, A.; Kobayashi, J.; Yamagishi, M.; Mabuchi, H.

Book ID: 118636672
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 70 KB
Volume: 9
Category: Article
ISSN: 1567-5688
DOI: 10.1016/s1567-5688(08)70830-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of ezetimibe added t

Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia

✍ Claude Gagné; Harold E Bays; Stuart R Weiss; Pedro Mata; Katherine Quinto; Micha 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Long-Term Safety and Efficacy of Mipomer

Long-Term Safety and Efficacy of Mipomersen in Patients with Familial Hypercholesterolemia Uncontrolled by Maximally Tolerated Lipid Lowering Therapy

✍ P. Barton Duell; Raul D. Santos; Cara East; John R. Guyton; Patrick M. Moriarty; 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 48 KB

Ezetimibe for the Treatment of Uncontrol

Ezetimibe for the Treatment of Uncontrolled Hypercholesterolemia in Patients with High-Dose Statin Therapy After Renal Transplantation

✍ M. Kohnle; F. Pietruck; A. Kribben; Th. Philipp; U. Heemann; O. Witzke 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Efficacy and Safety of Alirocumab in Pat

Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia not Adequately Controlled with Current Lipid-Lowering Therapy: Design and Rationale of the ODYSSEY FH Studies

✍ Kastelein, John J. P.; Robinson, Jennifer G.; Farnier, Michel; Krempf, Michel; L 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 293 KB